Inventor · disambiguated record
Masaru Taniguchi
Also filed as: TANIGUCHI MASARU
30 granted patents·10 pending applications·309 citations·filing 1987–2023
96Inventor score
Top patents by PatentIndex Score
40 records- 0193US6747010B2NKT cell-activating agents containing α-glycosylceramidesKIRIN BREWERY·Filed 2003·Granted Jun 8, 2004·73 cites·30 claims
- 0290US6531453B1NKT cell activators containing α-glycosylceramidesKIRIN BREWERY·Filed 1999·Granted Mar 11, 2003·97 cites·10 claims
- 0388USD643855SAir cylinderSMC CORP·Filed 2010·Granted Aug 23, 2011·40 cites·1 claims
- 0487US8945922B2Generating a mature NKT cell from a reprogrammed somatic cell with a T-cell antigen receptor α-chain region rearranged to uniform Va-Ja in a NKT-cell specific wayWATARAI HIROSHI·Filed 2009·Granted Feb 3, 2015·18 cites·17 claims
- 0580USD643856SAir cylinderSMC CORP·Filed 2010·Granted Aug 23, 2011·26 cites·1 claims
- 0679US8580751B2Esterified α-galactosylceramideSHIOZAKI MASAO·Filed 2009·Granted Nov 12, 2013·4 cites·15 claims
- 0778US7805294B2Wireless communication apparatus and wireless communication methodKENWOOD CORP·Filed 2005·Granted Sep 28, 2010·7 cites·6 claims
- 0876US8299223B2Pseudoglycolipid and use thereofTASHIRO TAKUYA·Filed 2008·Granted Oct 30, 2012·4 cites·6 claims
- 0973US9101558B2Use of anti-cancer cell composition for treatment of head and neck cancer, which is intended to be administered to nutrient artery of tumorTANIGUCHI MASARU·Filed 2008·Granted Aug 11, 2015·1 cites·9 claims
- 1073US8853173B2Synthetic glycolipid and use thereofTASHIRO TAKUYA·Filed 2011·Granted Oct 7, 2014·1 cites·13 claims
- 1173US7738436B2Wireless communication system, wireless communication control apparatus, wireless communication apparatus and wireless communication methodKENWOOD CORP·Filed 2005·Granted Jun 15, 2010·5 cites·13 claims
- 1272US8551959B2Glycolipid and use thereofTASHIRO TAKUYA·Filed 2009·Granted Oct 8, 2013·2 cites·12 claims
- 1371US12020824B2Virtual reality video reproduction apparatus, and method of using the sameSUMITOMO PHARMA CO LTD·Filed 2022·Granted Jun 25, 2024·0 cites·12 claims
- 1471US8163705B2Glycolipid and use thereofTASHIRO TAKUYA·Filed 2007·Granted Apr 24, 2012·3 cites·12 claims
- 1570US11495358B2Virtual reality video reproduction apparatus, and method of using the sameSUMITOMO PHARMA CO LTD·Filed 2021·Granted Nov 8, 2022·0 cites·14 claims
- 1669US8920774B2Drug having regulatory cell ligand contained in liposomeISHII YASUYUKI·Filed 2010·Granted Dec 30, 2014·2 cites·8 claims
- 1769US8173608B2Compound having cyclic structure and use thereofFUHSHUKU KEN-ICHI·Filed 2006·Granted May 8, 2012·3 cites·18 claims
- 1862US2025152701A1Nkt cell ligand-containing liposome compositionRIKEN·Filed 2023·Application pending·0 cites
- 1961US9387170B2Drug having regulatory cell ligand contained in liposomeRIKEN·Filed 2014·Granted Jul 12, 2016·0 cites·6 claims
- 2059US4800155AHuman monoclonal antibody to lung carcinoma and hybridoma producing the sameYOSHITOMI PHARMACEUTICAL·Filed 1987·Granted Jan 24, 1989·22 cites·5 claims
- 2155US8454955B2Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophiliaWATARAI HIROSHI·Filed 2008·Granted Jun 4, 2013·0 cites·5 claims
- 2255US8144809B2Modulating apparatus, mobile communication system, modulating method, and communication methodTANIGUCHI MASARU·Filed 2009·Granted Mar 27, 2012·0 cites·6 claims
- 2354US2007104776A1Drug having regulatory cell ligand contained in liposomeRIKEN·Filed 2006·Application pending·0 cites
- 2453US8199854B2Modulating apparatus, mobile communication system, modulating method, and communication methodTANIGUCHI MASARU·Filed 2009·Granted Jun 12, 2012·0 cites·2 claims
- 2553US2011231944A1B cell-derived ips cells and application thereofRIKEN·Filed 2009·Application pending·0 cites
- 2652US7928088B2Th1 cell differentiation acceleratorRIKEN·Filed 2007·Granted Apr 19, 2011·0 cites·14 claims
- 2752US7702033B2Modulating apparatus, mobile communication system, modulating method, and communication methodKENWOOD CORP·Filed 2004·Granted Apr 20, 2010·1 cites·6 claims
- 2850US2009214596A1Nasal VaccineRIKEN·Filed 2006·Application pending·0 cites
- 2948US2013209485A1Therapeutic agent of non-allergic airway inflammation and/or non-allergic hyperresponsive airwayRIKEN·Filed 2012·Application pending·0 cites
- 3048US2010129339A1Nkt cell-stimulating agent for administration through upper respiratory tract mucous membraneRIKEN·Filed 2006·Application pending·0 cites
- 3145US10813950B2Immunotherapy using allo-NKT cells, cells for immunotherapy in which alpha chain of t-cell receptor (TCR) gene has been rearranged to uniform Vα-Jα, and banking of NKT cells derived from said cellsTANIGUCHI MASARU·Filed 2011·Granted Oct 27, 2020·0 cites·9 claims
- 3245US2011020932A1In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitutionRIKEN·Filed 2007·Application pending·0 cites
- 3344US2009162869A1Membrane molecule expressed specifically in activated plasmacytoid dendritic cellRIKEN·Filed 2006·Application pending·0 cites
- 3443US9493497B2Carbamate glycolipid and use thereofRIKEN·Filed 2013·Granted Nov 15, 2016·0 cites·16 claims
- 3543US7826403B2Wireless communication control apparatus and wireless communication method to reduce inter-channel interference in narrow-band communicationsKENWOOD CORP·Filed 2005·Granted Nov 2, 2010·0 cites·6 claims
- 3643US2012160093A1Air cylinderTANIGUCHI MASARU·Filed 2009·Application pending·0 cites
- 3742US9464105B2Hydroxylated KRN7000 analogue and use thereofRIKEN·Filed 2013·Granted Oct 11, 2016·0 cites·14 claims
- 3839US11744860B2Technology for efficient activation of NKT cellsRIKEN·Filed 2017·Granted Sep 5, 2023·0 cites·14 claims
- 3937US2010083393A1Method of constructing clone mammalRIKEN·Filed 2005·Application pending·0 cites
- 4025US5648332AMethod of treating diabetes mellitus using variable α domain of T-cell receptorHOECHST JAPAN·Filed 1994·Granted Jul 15, 1997·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Masaru Taniguchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →